BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 23 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5 | -50.0% | 14,000 | +2.2% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 13,700 | 0.0% | 0.00% | – |
| Q3 2022 | $16,000 | 0.0% | 13,700 | +2.2% | 0.00% | – |
| Q2 2022 | $16,000 | -83.0% | 13,400 | -49.7% | 0.00% | – |
| Q4 2020 | $94,000 | -91.0% | 26,631 | -83.3% | 0.00% | -100.0% |
| Q3 2020 | $1,048,000 | -23.8% | 159,571 | -13.8% | 0.00% | 0.0% |
| Q2 2020 | $1,375,000 | +30.1% | 185,071 | -17.5% | 0.00% | 0.0% |
| Q1 2020 | $1,057,000 | – | 224,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 448,101 | $537,000 | 0.11% |
| Long Focus Capital Management, LLC | 327,692 | $393,000 | 0.04% |
| Boxer Capital, LLC | 56,950 | $68,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $16,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $299,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $54,000 | 0.00% |
| Orion Capital Management LLC | 500 | $1,000 | 0.00% |
| Parallel Advisors, LLC | 10 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 779 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $13,000 | 0.00% |